More recently, another study conducted by Jing et al. (2015) examined 36 colorectal primary adenocarcinomas with synchronous hepatic metastasis and found CD44, but not CD133, expression was independent factor associated with survival [35]. This evidence concerns the gene CD44 and adenocarcinoma.